secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corvus Pharmaceuticals, Inc. (CRVS)
CIK:        0001626971
Form:       8-K
Filed at:   2026-07-22T20:02:21+00:00
Accession:  0001104659-26-085790
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Ian T. Clark resigns from Corvus board effective July 22, 2026
-----------------------------------------------------------------------

- Ian T. Clark delivered notice of resignation from the Board on July 21, 2026, effective July 22, 2026.
- Clark served on the Board for over nine years; the Company thanked him for his contributions.
- No replacement director has been announced as of the filing date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1626971/000110465926085790/0001104659-26-085790-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1626971/000110465926085790/crvs-20260721x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-085790

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer